On July 7, 2022, the Centers for Medicare and Medicaid Services (CMS) released its proposed 2023 Medicare Physician Fee Schedule (PFS) rule. Learn more about this rule by checking out this article released by Foley and Lardner.
On July 7, 2022, the Centers for Medicare & Medicaid Services (CMS) proposed five new changes to Remote Therapeutic Monitoring (RTM) services under the Medicare program. The changes are part of the proposed 2023 Medicare Physician Fee Schedule rule. To learn more check out this Foley & Lardner article.
In light of recent state-level trends, businesses have begun exploring avenues to assist employees in states with restrictive abortion laws with travel to nearby states to receive abortion services. In implementing these programs, employers should consider the various ERISA and tax code-related provisions that may impact design.
T
his article was published by Seyfarth Shaw LLP on May 13, 2022.
Some states have restricted medical care for employees such as restricting abortions and gender-affirming care. In this sample policy Glowforge Inc. pays for the travel or relocation to get the healthcare the company has promised its employees. The policy was issued on April 14, 2022.
Learn about enforcement action taken by the US Centers for Medicare and Medicaid Services (CMS) in 2022 against hospitals, to enforce CMS's Hospital Price Transparency Rule that took effect on January 1, 2021.
This resource from Foley and Lardner provides insight into the most prominent trends throughout 2023. These trends are focused on the health care and life sciences sector.
This sample agreement is intended to satisfy the covered entity’s, company’s, and vendor’s obligations under HIPAA and is incorporated into all applicable services agreements between the company and its contracted vendor.
In recent years, companies specializing in artificial intelligence (AI) technologies have been increasingly coveted acquisition targets. Foley & Lardner have provided insight into the AI field transforming our approaches to key issues. Accordingly, it is no surprise that AI has emerged as a prime sector for M&A activity. This guide helps breakdown how to approach risks and rewards in dealing with the rising importance of Artificial Intelligence.
This guide provided by Foley & Lardner summarizes the key elements and requirements contained in the proposed rule. In addition it explains how it differs from the special telemedicine registration rule. Finally, it describes what stakeholders can do to make their voice heard, including by submitting comments to the proposed rule, during these next 30 days.
This blog explores the U.S. Food & Drug Administration (FDA) two final guidance documents to assist with transitioning medical devices: (i) that were subject to certain enforcement policies issued during the COVID-19 Public Health Emergency (PHE), and (ii) that were issued emergency use authorizations (EUAs). These guidance documents finalize the corresponding draft guidance documents that were issued on December 23, 2021.